Differential (Click to cross reference) acetylcholine receptor acetylcholine receptor antibody adverse drug reaction anticholinesterase anticonvulsants antistriational muscle antibody apnea arthralgia arthrogryposis multiplex ataxia atropine autoimmune disease azathioprine Bell's phenomenon bulbar palsy chemical weapons cholinergic crisis cholinergic drug chronic fatigue syndrome clubfoot as related to neurologic disease cognition Collier's sign coma complications confusion congenital myasthenic syndromes consanguinity controversies in neurology cyclosporine cytokines DEET developmental retardation diplopia electromyogram electromyogram, decremental response emergencies, neurologic exome sequencing eye closure facial weakness fatigue gammaglobulin therapy, intravenous gene mutation Gulf War syndrome headache high arched palate immunologic disease immunosuppressive agents insect repellent insecticides level of consciousness, decreased lid abnormalities lid closure, weakness of lid twitch malabsorption malformation, CNS, congenital mediastinum, mass of mestinon microcephaly miosis misdiagnosis mortality muscle biopsy muscle pain muscle weakness, proximal myasthenia gravis myasthenia gravis, anticholinesterase malabsorption in myasthenia gravis, anticholinesterase serum levels in myasthenia gravis, classification myasthenia gravis, diagnosis myasthenia gravis, differential diagnosis myasthenia gravis, drug induced myasthenia gravis, etiology of myasthenia gravis, infantile and juvenile myasthenia gravis, misdiagnosis of myasthenia gravis, neuromuscular junction in myasthenia gravis, ocular myasthenia gravis, presenting manifestations myasthenia gravis, prognosis of myasthenia gravis, receptor site in myasthenia gravis, remission of myasthenia gravis, seronegative myasthenia gravis, thymectomy in myasthenia gravis, treatment of myasthenic crisis mycophenolate nasal speech nausea and vomiting nerve agents neurologic disease, diagnoses of neurologic signs neurologic symptoms neuromuscular blockade neuromuscular disease, electrodiagnosis of neuromuscular junction neuromuscular junction, abnormality of neuroophthalmology neuropathy neuropathy, toxic neurotoxic neurotoxin nystagmus ocular motility, disorders of opened mouth ophthalmoplegia penicillamine plasmapheresis poison, neurologic problems with poison, organophosphate polyneuropathy practice guidelines pregnancy, neurologic complications in prognosis pseudointernuclear ophthalmoplegia ptosis ptosis, bilateral quinine repetitive nerve stimulation respiratory failure respiratory paralysis, pharmacologic review article rhinorrhea risk factors risk-benefit assessment saccadic eye movements saccadic eye movements, abnormal salivation, excessive Sarin seizure seronegative single-fiber electromyography sleep Soman steroid steroid therapy, CNS treatment and complications with Tabun tensilon tensilon test, false negative tensilon test, false positive tensilon test, paradoxical thymectomy thymoma thymus and neuromuscular function toxins, nervous system treatment of neurologic disorder upgaze, paralysis of vaccination, neurologic complications with VX war weakness weakness, fatiguable weakness, generalized weakness, proximal

Showing articles 0 to 15 of 15 A Child with Arthrogryposis Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018 International Consensus Guidance for Management of Myasthenia Gravis Neurol 87:419-425, Sanders, D.B.,et al, 2016 Ocular Myasthenia Gravis Treatment: The Case Against Prednisone Therapy and Thymectomy Arch Neurol 64:1790-1792,1794, Gilbert,M.E.,et al, 2007 Therapy for Nerve Agent Poisoning Arch Neurol 61:649-652, Newmark,J., 2004 Management of Myasthenia Gravis Semin Neurol 24:41-48, Saperstein,D.S. &Barohn,R.J., 2004 Pyridostigmine-Induced Microcephaly Neurol 54:1873-1874, Niesen,C.E.&Shah,N.S., 2000 Self-Reported Exposure to Neurotoxic Chemical Combinations in the Gulf War:A Cross-Sectional Epidemiologic Study JAMA 227:231-237, 2591997., Haley,R.W.&Kurt,T.L., 1997 Myasthenia Gravis NEJM 330:1797-1810, Drachman,D.B., 1994 Ocular Myasthenia:A Protean Disorder Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994 Nerve Agents:A Review Neurol 42:946-950, Gunderson,C.H.,et al, 1992 Management of Injuries Due to Chemical Weapons BMJ 302:129-130, Murray,V.S.G.&Volans,G.N., 1991 Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions JAMA 266:693-695, Keeler,J.R.,et al, 1991 Plasma Pyridostigmine Levels in Myasthenia Gravis Neurol 31:145-150, White,M.C.,et al, 1981 Controversies About the Treatment of Myasthenia Gravis JNNP 43:644-659, Rowland,L.P., 1980 Malabsorption of Pyridostigmine in Patients with Masthenia Gravis Neurol 27:299, Cohan,S.L.,et al, 1977 Showing articles 0 to 15 of 15